Cohance Lifesciences Receives Strong ESG Rating

Date: 6 October 2026

ESG Rating Disclosure

Crisil ESG Ratings & Analytics Limited (Crisil ESG Ratings) has voluntarily assigned an ESG Rating of "Crisil ESG 61 (Strong)" to Cohance Lifesciences Limited. The company also received a Core ESG Rating of "Crisil Core ESG 67 (Strong)".

The rating was independently determined by Crisil ESG Ratings based on publicly available information pertaining to the Company. The Company confirmed it has not engaged Crisil ESG Ratings for this ESG Rating.

The disclosure is made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated 30 January 2026.

The rating publication link is provided: https://www.crisilesg.com/en/home/esg-ratings.html